Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABCA2,ATP-binding cassette sub-family A member 2,19234,1836,1.45 [1.28-1.63],9.95519110319954e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22405,2098,1.35 [1.29-1.40],4.216891965750463e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAN,Aggrecan core protein,22706,2139,0.50 [0.44-0.58],7.659071547716284e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE,Angiotensin-converting enzyme,19935,1893,1.89 [1.62-2.20],6.222627868041164e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE2,Angiotensin-converting enzyme 2,22530,2127,1.68 [1.59-1.78],3.9754772720042313e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP5,Tartrate-resistant acid phosphatase type 5,23040,2178,2.09 [1.87-2.33],5.864718523295305e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY1,Aminoacylase-1,22943,2160,1.81 [1.71-1.91],1.246561919001007e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19234,1836,1.60 [1.49-1.72],2.775070856294501e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA2,Adenosine deaminase 2,22831,2143,2.21 [2.04-2.40],3.502533556297486e-84
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19320,1836,1.56 [1.38-1.77],2.3652636498568825e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,23118,2173,1.51 [1.33-1.70],4.9398328976503615e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19848,1888,1.59 [1.39-1.82],3.7854299839779786e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23232,2193,1.83 [1.56-2.14],5.3875670566222563e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL2,ADAMTS-like protein 2,19921,1897,2.96 [2.70-3.26],2.453353617122168e-113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRD1,Adhesion G-protein coupled receptor D1,19456,1848,1.59 [1.43-1.76],1.9154290541356812e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE2,Adhesion G protein-coupled receptor E2,23025,2168,2.05 [1.81-2.33],4.1198129815750707e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE5,Adhesion G protein-coupled receptor E5,23120,2184,2.04 [1.85-2.26],5.9220410078542826e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG1,Adhesion G-protein coupled receptor G1,22833,2139,1.54 [1.49-1.59],2.211396052826737e-141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG2,Adhesion G-protein coupled receptor G2,22943,2160,0.58 [0.52-0.64],8.451613710145959e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH1B,All-trans-retinol dehydrogenase,19456,1848,1.37 [1.30-1.44],1.5179817696941255e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22530,2127,1.44 [1.38-1.51],1.114712158505903e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADIPOQ,Adiponectin,19935,1892,0.58 [0.54-0.62],3.9594815845169603e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADM,Pro-adrenomedullin,23146,2176,1.72 [1.48-2.00],5.910632869469289e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFM,Afamin,19935,1892,4.17 [3.39-5.14],4.4228892273706047e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR2,Anterior gradient protein 2 homolog,22282,2095,1.18 [1.13-1.22],1.0049492264700684e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR3,Anterior gradient protein 3,22369,2093,1.29 [1.21-1.37],7.527617043819606e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRN,Agrin,23025,2168,1.77 [1.62-1.93],7.704887360033912e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGXT,Serine--pyruvate aminotransferase,22943,2160,1.44 [1.37-1.50],1.1214973404027448e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22801,2137,1.17 [1.13-1.21],6.877364708583967e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B10,Aldo-keto reductase family 1 member B10,19370,1843,1.38 [1.31-1.46],1.6208589074613268e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,19320,1836,1.41 [1.33-1.48],5.929415342694164e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALCAM,CD166 antigen,23232,2193,2.76 [2.32-3.30],1.4409571874632738e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH1A1,Retinal dehydrogenase 1,22954,2166,1.48 [1.40-1.57],3.771521176645812e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22878,2161,1.31 [1.25-1.36],6.617569985694633e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19874,1884,1.31 [1.21-1.43],4.86886012614759e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMBP,Protein AMBP,23111,2175,2.13 [1.77-2.56],1.602445440656291e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMIGO2,Amphoterin-induced protein 2,22833,2139,1.97 [1.68-2.31],6.130770524059808e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMOT,Angiomotin,19456,1848,1.73 [1.55-1.93],1.0038900549718852e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT2,Angiopoietin-2,23146,2176,2.04 [1.85-2.24],8.447642121986415e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL2,Angiopoietin-related protein 2,22946,2160,1.67 [1.52-1.83],2.9992464365252128e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL3,Angiopoietin-related protein 3,22986,2161,0.58 [0.53-0.64],1.7490460697016206e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL4,Angiopoietin-related protein 4,22989,2166,1.47 [1.35-1.60],3.8921353790343103e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL7,Angiopoietin-related protein 7,23146,2176,1.92 [1.75-2.11],2.1785989419796402e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA10,Annexin A10,22446,2110,1.15 [1.10-1.21],1.5864071626620562e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AOC3,Membrane primary amine oxidase,23056,2165,2.77 [2.46-3.12],3.5010557472818572e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA1,Apolipoprotein A-I,19935,1892,0.44 [0.36-0.53],1.5358851932304451e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA4,Apolipoprotein A-IV,19935,1892,1.76 [1.58-1.95],4.069823596602129e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOC1,Apolipoprotein C-I,19902,1887,0.48 [0.43-0.54],1.1800325764945183e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOD,Apolipoprotein D,19058,1808,0.34 [0.29-0.39],2.1089375037124808e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOF,Apolipoprotein F,19935,1893,0.43 [0.38-0.48],1.0692734764762512e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOM,Apolipoprotein M,23022,2164,0.34 [0.30-0.38],3.4027931273407447e-68
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AREG,Amphiregulin,22833,2139,2.20 [2.03-2.38],5.362806625460642e-82
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARSA,Arylsulfatase A,22954,2166,1.38 [1.28-1.49],8.417883452423223e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH2,Neutral ceramidase,22750,2153,1.81 [1.67-1.97],2.6353504629549908e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR1,Asialoglycoprotein receptor 1,22750,2153,2.66 [2.39-2.96],2.6170645986545e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASS1,Argininosuccinate synthase,19234,1836,1.31 [1.24-1.39],2.094482310493264e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRN,"Attractin, Isoform 2",19935,1892,3.97 [3.13-5.05],1.7035365449073625e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19360,1834,2.62 [2.32-2.95],2.5417971192415168e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",23025,2168,1.64 [1.43-1.87],3.8107410832653894e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22405,2098,1.56 [1.48-1.64],4.631554530421803e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAP18,Chromatin complexes subunit BAP18,19860,1881,1.19 [1.13-1.26],4.598263845432153e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAM,Basal cell adhesion molecule,22954,2166,1.58 [1.37-1.83],4.0884247075353005e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAN,Brevican core protein,22750,2153,0.54 [0.49-0.60],8.844221140788106e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BGLAP,Osteocalcin,19921,1897,0.84 [0.80-0.88],1.9885540009218564e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP6,Bone morphogenetic protein 6,22494,2126,1.35 [1.23-1.48],4.779054361862506e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMPER,BMP-binding endothelial regulator protein,19456,1848,3.14 [2.65-3.73],4.828702273692092e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB2,BPI fold-containing family B member 2,19878,1887,1.41 [1.33-1.49],3.4616523384458626e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST2,Bone marrow stromal antigen 2,23155,2176,1.45 [1.36-1.54],2.4379497862365524e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN2A1,Butyrophilin subfamily 2 member A1,23025,2168,1.59 [1.40-1.82],5.1429658183260676e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C19orf12,Protein C19orf12,22446,2110,1.39 [1.33-1.46],1.5297604887428862e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,23056,2165,1.83 [1.70-1.97],5.469819276918148e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1RL,Complement C1r subcomponent-like protein,19895,1886,2.13 [1.69-2.68],1.2507712798611864e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2,Complement C2,23022,2164,3.26 [2.69-3.96],8.487899455890946e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C3,Complement C3,18905,1784,1.43 [1.31-1.55],7.586707581195854e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7,Complement component C7,19450,1848,2.76 [2.42-3.15],8.3325778449253305e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C9,Complement component C9,19935,1893,0.80 [0.74-0.86],4.739730718902014e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA12,Carbonic anhydrase 12,22833,2139,1.58 [1.41-1.76],4.732618519838452e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA14,Carbonic anhydrase 14,23146,2176,0.48 [0.43-0.53],8.960053693773728e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",22530,2127,1.23 [1.19-1.28],6.530781407249825e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA6,Carbonic anhydrase 6,22887,2158,0.78 [0.74-0.83],2.6816625471341668e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA9,Carbonic anhydrase 9,23146,2176,1.40 [1.30-1.51],1.049295456055574e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLIF,Cobalamin binding intrinsic factor,22913,2159,1.25 [1.19-1.31],1.3862525774124418e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLN4,Cerebellin-4,23146,2176,1.48 [1.33-1.64],9.897806852727862e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBS,Cystathionine beta-synthase,19360,1834,1.49 [1.39-1.60],2.132593003249537e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL11,Eotaxin,23215,2189,1.56 [1.41-1.72],9.802828407695779e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL15,C-C motif chemokine 15,23232,2193,1.75 [1.62-1.89],1.293660167899205e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL16,C-C motif chemokine 16,23232,2193,1.37 [1.27-1.47],3.113237760695006e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL20,C-C motif chemokine 20,23215,2189,1.26 [1.22-1.31],9.461946239794349e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL21,C-C motif chemokine 21,23025,2168,1.45 [1.34-1.57],3.133553037401896e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL25,C-C motif chemokine 25,23215,2189,1.29 [1.19-1.39],1.2803937341014903e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL3,C-C motif chemokine 3,22920,2165,1.16 [1.11-1.21],2.1517718486246992e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL7,C-C motif chemokine 7,22920,2165,1.24 [1.17-1.32],4.833724484513586e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN4,CCN family member 4,23146,2176,1.49 [1.36-1.62],6.454416021706846e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD101,Immunoglobulin superfamily member 2,19848,1888,1.39 [1.25-1.54],9.839868461647383e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD109,CD109 antigen,22954,2166,1.70 [1.52-1.91],1.7447135620594102e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD14,Monocyte differentiation antigen CD14,22519,2123,1.35 [1.23-1.48],2.0732055220962718e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,23056,2165,1.81 [1.67-1.96],2.6881199813975543e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164,Sialomucin core protein 24,22954,2166,1.40 [1.28-1.54],6.654012376062219e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD22,B-cell receptor CD22,23215,2189,1.54 [1.42-1.67],2.51428184128462e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD244,Natural killer cell receptor 2B4,23215,2189,1.67 [1.46-1.91],5.01746879833127e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD248,Endosialin,19921,1897,0.61 [0.54-0.68],4.009618135066874e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD27,CD27 antigen,23005,2159,1.48 [1.36-1.61],1.0683613705209936e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD274,Programmed cell death 1 ligand 1,22750,2153,1.43 [1.29-1.59],1.898532400839164e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD276,CD276 antigen,22907,2158,1.67 [1.49-1.86],3.7594244313774323e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD28,T-cell-specific surface glycoprotein CD28,22405,2098,1.58 [1.45-1.73],9.061888885142364e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300C,CMRF35-like molecule 6,23155,2176,1.45 [1.31-1.61],1.20230582901507e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LG,CMRF35-like molecule 9,22954,2166,0.60 [0.54-0.67],1.5482696081011865e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD34,Hematopoietic progenitor cell antigen CD34,23086,2170,0.53 [0.46-0.63],7.35535247140947e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD4,T-cell surface glycoprotein CD4,22882,2163,1.54 [1.38-1.73],8.459459436872179e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD48,CD48 antigen,22989,2166,1.78 [1.58-2.01],1.5001622663850615e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD5,T-cell surface glycoprotein CD5,23111,2175,1.57 [1.45-1.71],3.78015500858911e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD63,CD63 antigen,22707,2149,1.29 [1.19-1.39],1.0809365182318475e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD72,B-cell differentiation antigen CD72,19456,1848,1.41 [1.27-1.56],1.8101099671923085e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD74,HLA class II histocompatibility antigen gamma chain,23155,2176,1.72 [1.55-1.91],2.0322899920615475e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD80,T-lymphocyte activation antigen CD80,19913,1888,2.50 [2.26-2.77],1.747416979426068e-68
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD83,CD83 antigen,22920,2165,1.70 [1.54-1.89],7.308235834264112e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,23155,2176,1.39 [1.30-1.50],1.64646278780613e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDCP1,CUB domain-containing protein 1,22750,2153,1.61 [1.52-1.71],3.746969542205199e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH1,Cadherin-1,22194,2081,1.61 [1.50-1.72],6.411315692615421e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH15,Cadherin-15,23123,2171,1.41 [1.35-1.47],2.391434300176425e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH17,Cadherin-17,22943,2160,1.41 [1.34-1.49],1.336851204032275e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH2,Cadherin-2,22943,2160,2.75 [2.49-3.03],4.455965972986575e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH6,Cadherin-6,22943,2160,1.44 [1.31-1.58],8.456159993327337e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR2,Cadherin-related family member 2,22833,2139,1.56 [1.46-1.66],1.4524280480988093e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22972,2157,1.93 [1.64-2.26],4.779102858241197e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,22121,2077,1.23 [1.16-1.31],2.638534599256399e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19921,1897,1.40 [1.29-1.53],2.011801717611757e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEMIP2,Cell surface hyaluronidase,19320,1836,1.59 [1.46-1.74],1.5174686238307986e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES1,Liver carboxylesterase 1,23009,2171,1.40 [1.35-1.46],8.717499292604117e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES2,Cocaine esterase,22833,2139,1.34 [1.26-1.43],8.117310387266799e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFB,Complement factor B,19585,1855,2.17 [1.89-2.50],3.355981855464956e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFC1,Cryptic protein,22405,2098,1.32 [1.22-1.42],3.286750708768593e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFH,Complement factor H,18782,1780,3.21 [2.65-3.88],2.247582618952524e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR4,Complement factor H-related protein 4,19893,1890,0.83 [0.78-0.88],6.35797797939686e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFI,Complement factor I,19935,1892,4.07 [3.26-5.08],2.64275941546479e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGA,Glycoprotein hormones alpha chain,22954,2166,1.27 [1.20-1.35],5.995893323160069e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGREF1,Cell growth regulator with EF hand domain protein 1,22943,2160,1.43 [1.31-1.56],9.026750029087875e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHAD,Chondroadherin,19456,1848,0.48 [0.44-0.53],7.9641483584106095e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19860,1881,1.70 [1.57-1.85],2.7676260059311364e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD6,MICOS complex subunit MIC25,19841,1877,1.51 [1.36-1.68],3.764669887879481e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHI3L1,Chitinase-3-like protein 1,22469,2108,1.30 [1.25-1.35],5.873477480540028e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRDL2,Chordin-like protein 2,22943,2160,1.35 [1.24-1.46],4.677002587694687e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CILP,Cartilage intermediate layer protein 1,19921,1897,1.70 [1.57-1.85],2.4056729797906717e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKB,Creatine kinase B-type,19921,1897,0.59 [0.55-0.64],3.816641301849615e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC3B,Tetranectin,19481,1844,0.44 [0.35-0.55],5.358127726214002e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4A,C-type lectin domain family 4 member A,22920,2165,0.67 [0.60-0.74],2.6079359173219563e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4D,C-type lectin domain family 4 member D,22920,2165,1.26 [1.19-1.34],1.9123269223697936e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC6A,C-type lectin domain family 6 member A,22405,2098,1.33 [1.23-1.44],1.90706725393908e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN2,Calsyntenin-2,23215,2189,1.56 [1.44-1.70],6.975345754955944e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN3,Calsyntenin-3,19860,1881,1.75 [1.53-2.00],6.84535416826635e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLUL1,Clusterin-like protein 1,22901,2157,0.74 [0.68-0.81],6.546091738926307e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN2,Contactin-2,23146,2176,1.44 [1.32-1.57],1.9802082048228666e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN3,Contactin-3,22954,2166,2.45 [2.14-2.81],5.1295250127609216e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN4,Contactin-4,22954,2166,1.87 [1.60-2.19],1.1053982787310216e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL15A1,Collagen alpha-1(XV) chain,19921,1897,0.53 [0.45-0.62],2.7640886652176867e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL18A1,Collagen alpha-1(XVIII) chain,23045,2175,1.64 [1.40-1.92],7.578352137925855e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL3A1,Collagen alpha-1(III) chain,19921,1897,2.10 [1.77-2.50],3.8746190957833626e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL4A1,Collagen alpha-1(IV) chain,22943,2160,1.38 [1.26-1.52],3.183521369982536e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL5A1,Collagen alpha-1(V) chain,19456,1848,1.71 [1.56-1.87],8.452251479224095e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL6A3,Collagen alpha-3(VI) chain,23232,2193,1.50 [1.36-1.66],1.3599724992089116e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COLEC12,Collectin-12,22907,2158,1.62 [1.41-1.85],5.182043105995853e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA2,Carboxypeptidase A2,23087,2168,1.40 [1.33-1.48],2.890796063492236e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPM,Carboxypeptidase M,23038,2161,3.16 [2.86-3.49],2.136210846342379e-112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR1,Complement receptor type 1,19860,1883,1.49 [1.32-1.68],2.3509968757596496e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR2,Complement receptor type 2,23056,2165,1.47 [1.36-1.60],1.4068937685976278e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD1,Protein disulfide isomerase CRELD1,19456,1848,2.11 [1.88-2.37],1.0219820674189309e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRH,Corticoliberin,22369,2095,0.80 [0.76-0.84],8.62479003335169e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRHBP,Corticotropin-releasing factor-binding protein,22907,2158,2.45 [2.14-2.81],1.473776858476933e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIP2,Cysteine-rich protein 2,22750,2153,1.47 [1.35-1.60],2.026610108196639e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRLF1,Cytokine receptor-like factor 1,23025,2168,1.74 [1.50-2.02],7.597618560206716e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRNN,Cornulin,22298,2085,0.81 [0.77-0.86],1.2893749020592437e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAC1,Cartilage acidic protein 1,23232,2193,0.63 [0.56-0.71],2.3737667888370848e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1,Macrophage colony-stimulating factor 1,23025,2168,1.85 [1.62-2.12],5.208994532576414e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,19935,1893,1.79 [1.62-1.97],1.4655196265364393e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTBS,Di-N-acetylchitobiase,19652,1861,2.30 [1.97-2.68],5.389965245689848e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSB,Cathepsin B,22968,2165,0.77 [0.71-0.83],8.322979692173337e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSD,Cathepsin D,21471,2021,2.00 [1.87-2.14],1.204022906390091e-89
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSE,Cathepsin E,19456,1848,1.33 [1.22-1.45],2.6082264503531887e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSL,Cathepsin L1,22943,2160,1.62 [1.39-1.88],2.9419735601576376e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSO,Cathepsin O,23215,2189,2.56 [2.31-2.84],6.086097127963912e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSS,Cathepsin S,18054,1705,2.80 [2.32-3.38],1.8356289384190936e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSZ,Cathepsin Z,22985,2157,1.87 [1.66-2.09],1.3095124790484996e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL13,C-X-C motif chemokine 13,23155,2176,1.20 [1.14-1.27],1.2045004547087249e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL17,C-X-C motif chemokine 17,23215,2189,1.38 [1.28-1.49],1.2184165594422188e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL8,Interleukin-8,22789,2139,1.19 [1.14-1.25],7.49660142620247e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYTL1,Cytokine-like protein 1,19921,1897,0.53 [0.44-0.63],2.9542572796391177e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAG1,Dystroglycan,23025,2168,1.49 [1.38-1.62],2.2634436702959808e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",23005,2159,1.87 [1.69-2.08],3.047729831455617e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCXR,L-xylulose reductase,23005,2159,1.47 [1.37-1.57],2.759813906761913e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22833,2139,1.51 [1.40-1.63],5.195875281185611e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDR1,Epithelial discoidin domain-containing receptor 1,23155,2176,2.10 [1.80-2.45],2.147697709083308e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB103A_DEFB103B,Beta-defensin 103,19174,1819,1.31 [1.21-1.43],2.375869106314293e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DHPS,Deoxyhypusine synthase,19841,1877,1.41 [1.28-1.54],4.656820939815143e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK4,Dickkopf-related protein 4,22707,2148,1.46 [1.35-1.58],7.172701567829065e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLL1,Delta-like protein 1,23005,2159,1.58 [1.40-1.78],1.4160753008660142e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMP1,Dentin matrix acidic phosphoprotein 1,19360,1834,0.60 [0.56-0.64],2.281393416530557e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP10,Inactive dipeptidyl peptidase 10,22920,2165,1.70 [1.56-1.85],7.470534697366658e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,22833,2139,2.16 [1.95-2.40],3.212896010682169e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPY30,Protein dpy-30 homolog,23084,2173,1.35 [1.28-1.43],2.7174336204346497e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSC2,Desmocollin-2,22679,2140,1.61 [1.45-1.78],1.2391575879447373e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSCAM,Down syndrome cell adhesion molecule,19874,1884,2.10 [1.87-2.36],2.9667429084209825e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTNB,Dystrobrevin beta,19798,1872,1.59 [1.46-1.73],2.1349302409007595e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19913,1888,1.34 [1.27-1.41],2.8700214427666415e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19360,1834,1.18 [1.13-1.23],6.737553978089804e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,23146,2176,1.45 [1.32-1.60],6.149145670750421e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA4,Ephrin-A4,22707,2149,2.09 [1.89-2.31],1.577104736132369e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGLN1,Egl nine homolog 1,22920,2165,1.22 [1.16-1.29],3.2381097074594423e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENO3,Beta-enolase,19360,1834,1.24 [1.16-1.32],2.7741286577284107e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,23232,2193,1.76 [1.53-2.03],9.945338976905756e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22247,2090,1.31 [1.25-1.37],2.5476613436755596e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22405,2098,1.51 [1.39-1.65],2.0452296387678e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22530,2127,0.50 [0.43-0.59],3.078143907578925e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTR1,Endosome-associated-trafficking regulator 1,19360,1834,1.24 [1.16-1.32],4.509598579145557e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA2,Ephrin type-A receptor 2,22088,2068,1.64 [1.46-1.84],2.9850806381458854e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPO,Erythropoietin,22920,2165,1.16 [1.11-1.21],2.1655502628921208e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,23111,2175,1.92 [1.73-2.14],3.922476989153708e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,23005,2159,2.39 [2.06-2.78],1.1798536313308972e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,23005,2159,2.37 [2.03-2.77],5.5645028005764135e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESM1,Endothelial cell-specific molecule 1,22907,2158,0.68 [0.61-0.76],1.4385993788247102e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EZR,Ezrin,23155,2176,1.68 [1.46-1.93],4.993478803189487e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F9,Coagulation factor IX,23022,2164,2.73 [2.22-3.35],1.0683377238690222e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP1,"Fatty acid-binding protein, liver",22907,2158,1.44 [1.38-1.49],1.5996510803808104e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP3,"Fatty acid-binding protein, heart",19913,1888,1.44 [1.34-1.55],2.857338128991318e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP4,"Fatty acid-binding protein, adipocyte",23232,2193,1.54 [1.44-1.65],4.4572499887072624e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM20A,Pseudokinase FAM20A,19913,1888,2.02 [1.77-2.30],6.181797007025295e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3B,Protein FAM3B,22833,2139,1.66 [1.49-1.85],5.3880301006421744e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3C,Protein FAM3C,22913,2159,2.02 [1.79-2.27],3.1961807569277825e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3D,Protein FAM3D,19848,1888,1.25 [1.19-1.32],3.8361423181288594e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAS,Tumor necrosis factor receptor superfamily member 6,23154,2188,1.38 [1.27-1.49],1.1971207075375152e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FASLG,Tumor necrosis factor ligand superfamily member 6,23215,2189,0.63 [0.57-0.70],4.961662094511595e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBP1,"Fructose-1,6-bisphosphatase 1",22943,2160,1.27 [1.21-1.33],1.0950213032440522e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19913,1888,1.60 [1.51-1.69],4.5621195400640514e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAR,Immunoglobulin alpha Fc receptor,22920,2165,1.42 [1.31-1.53],2.764432389007737e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF21,Fibroblast growth factor 21,23119,2174,1.23 [1.20-1.27],1.7428122059578445e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF23,Fibroblast growth factor 23,23107,2168,1.27 [1.19-1.35],1.1382914183710494e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP1,Fibroblast growth factor-binding protein 1,23005,2159,0.37 [0.33-0.41],1.2671323891595564e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP3,Fibroblast growth factor-binding protein 3,19860,1881,0.67 [0.59-0.75],2.503866948910605e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR2,Fibroblast growth factor receptor 2,23005,2159,3.55 [3.09-4.08],6.14385084148131e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,23215,2189,1.45 [1.30-1.61],1.4423850815979076e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL1,Follistatin-related protein 1,19360,1834,1.86 [1.53-2.26],4.370107729260976e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL3,Follistatin-related protein 3,22875,2157,1.55 [1.39-1.74],1.0358632828572316e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FTCD,Formimidoyltransferase-cyclodeaminase,19817,1876,1.46 [1.40-1.53],2.8073916942500858e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUOM,Fucose mutarotase,19456,1848,1.58 [1.48-1.68],1.6078950707346728e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FURIN,Furin,23005,2159,2.12 [1.89-2.38],4.355745845504675e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAL,Galanin peptides,23025,2168,0.79 [0.75-0.84],1.1550860104259225e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22833,2139,2.21 [1.94-2.52],1.1278107052083563e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22537,2110,1.47 [1.35-1.60],6.398487914332815e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT7,N-acetylgalactosaminyltransferase 7,22833,2139,1.92 [1.59-2.31],9.382422094831346e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAS6,Growth arrest-specific protein 6,23090,2181,1.69 [1.45-1.96],8.375346284843944e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAST,Gastrin,19860,1881,1.13 [1.09-1.16],1.617483132065712e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCG,Pro-glucagon,22405,2098,1.27 [1.23-1.31],4.7197059861296974e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22833,2139,1.51 [1.36-1.69],1.258959061213514e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF15,Growth/differentiation factor 15,23232,2193,2.58 [2.44-2.73],4.753166638942941e-247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF2,Growth/differentiation factor 2,22943,2160,1.47 [1.33-1.64],3.899399061192081e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDNF,Glial cell line-derived neurotrophic factor,22446,2110,1.51 [1.37-1.66],2.216954589354568e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFER,FAD-linked sulfhydryl oxidase ALR,22405,2098,1.20 [1.13-1.28],7.61919341939748e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA1,GDNF family receptor alpha-1,23119,2174,2.29 [2.02-2.59],1.5239205895033493e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGH,Gamma-glutamyl hydrolase,22569,2123,1.60 [1.44-1.78],1.2383438207423519e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT1,Glutathione hydrolase 1 proenzyme,22912,2163,1.65 [1.55-1.76],1.0207943774442672e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT5,Glutathione hydrolase 5 proenzyme,22750,2153,2.45 [2.13-2.81],2.8289954507980503e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHR,Growth hormone receptor,19456,1848,1.87 [1.59-2.21],1.1129782099274777e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHRL,Appetite-regulating hormone,22943,2160,0.83 [0.80-0.87],1.994420802731996e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPC2,PDZ domain-containing protein GIPC2,19860,1881,1.58 [1.39-1.80],4.587840466554561e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLA,Alpha-galactosidase A,19425,1846,1.96 [1.76-2.18],3.254871711313429e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLB1,Beta-galactosidase,22750,2153,1.47 [1.35-1.61],7.2516434030926455e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLM2,Protein GOLM2,23155,2176,2.56 [2.28-2.87],2.774436987261753e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPD1,Glycerol-3-phosphate dehydrogenase,19841,1877,1.79 [1.67-1.91],2.152403416533353e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPNMB,Transmembrane glycoprotein NMB,22323,2106,1.94 [1.70-2.22],6.61699432127365e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR37,Prosaposin receptor GPR37,22530,2127,1.28 [1.21-1.36],2.750634665428263e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPRC5C,G-protein coupled receptor family C group 5 member C,19841,1877,1.41 [1.32-1.49],8.901889570222524e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19913,1888,1.26 [1.18-1.35],6.285075038951427e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRN,Progranulin,22832,2156,1.87 [1.62-2.16],4.486708731555644e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",22833,2139,1.40 [1.32-1.48],2.191444481784104e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSN,Gelsolin,19849,1887,0.28 [0.23-0.33],5.410242335301871e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA1,Glutathione S-transferase A1,22907,2156,1.42 [1.36-1.48],1.728569906032955e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA3,Glutathione S-transferase A3,22405,2098,1.39 [1.33-1.45],2.4148857860763342e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUSB,Beta-glucuronidase,23040,2178,1.64 [1.55-1.73],4.206343215586659e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMA,Granzyme A,23215,2189,1.41 [1.27-1.57],2.96140390066972e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAO1,Hydroxyacid oxidase 1,23146,2176,1.28 [1.24-1.32],7.213511453734938e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR1,Hepatitis A virus cellular receptor 1,23111,2175,1.73 [1.64-1.81],7.901361639370411e-106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR2,Hepatitis A virus cellular receptor 2,22954,2166,1.63 [1.48-1.81],5.1802056812583885e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEG1,Protein HEG homolog 1,19456,1848,3.32 [2.85-3.86],2.197988382150096e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPH,Hephaestin,19913,1888,3.21 [2.69-3.84],2.3785539450200312e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGF,Hepatocyte growth factor,23215,2189,2.57 [2.35-2.81],1.7701224764828662e-95
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIP1R,Huntingtin-interacting protein 1-related protein,19819,1877,1.46 [1.37-1.55],7.995914442716745e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HJV,Hemojuvelin,19874,1884,1.49 [1.37-1.62],4.9526065170792974e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22847,2160,1.39 [1.25-1.53],2.005194578527868e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMCN2,Hemicentin-2,19420,1845,1.33 [1.23-1.44],1.1661725008740053e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNMT,Histamine N-methyltransferase,22645,2142,1.45 [1.35-1.57],2.3297509120259216e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19320,1836,1.46 [1.30-1.63],6.96158345302818e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22920,2165,0.46 [0.42-0.51],1.5283147326483668e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19860,1881,1.29 [1.20-1.38],6.382463431621927e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYAL1,Hyaluronidase-1,22846,2141,2.12 [1.81-2.47],4.802903844926621e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM1,Intercellular adhesion molecule 1,22864,2150,2.44 [2.16-2.75],7.553556353282268e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM4,Intercellular adhesion molecule 4,22920,2165,0.79 [0.73-0.85],5.8031444505195957e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM5,Intercellular adhesion molecule 5,22943,2160,1.29 [1.19-1.40],4.4943890240247047e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDUA,Alpha-L-iduronidase,23146,2176,1.66 [1.53-1.80],3.8667562055156665e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19384,1842,1.75 [1.58-1.94],8.020968564844103e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR2,Interferon gamma receptor 2,22750,2153,1.49 [1.39-1.59],7.262933023154249e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNLR1,Interferon lambda receptor 1,22920,2165,1.34 [1.22-1.47],2.996313188983005e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF2R,Cation-independent mannose-6-phosphate receptor,22954,2166,2.26 [1.94-2.63],1.1874791309327167e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP1,Insulin-like growth factor-binding protein 1,23201,2191,0.80 [0.78-0.83],2.1496707347810297e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP2,Insulin-like growth factor-binding protein 2,23198,2189,0.66 [0.62-0.71],1.5820192816375187e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP3,Insulin-like growth factor-binding protein 3,23056,2165,0.72 [0.65-0.80],2.6312219619514526e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP4,Insulin-like growth factor-binding protein 4,22682,2144,1.39 [1.28-1.50],6.821332849811657e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP7,Insulin-like growth factor-binding protein 7,23232,2193,1.80 [1.64-1.98],3.8887506894504455e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22943,2160,1.83 [1.66-2.02],1.57972805521976e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF3,Immunoglobulin superfamily member 3,22833,2139,2.27 [2.14-2.41],1.0274023938274142e-164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF8,Immunoglobulin superfamily member 8,22943,2160,1.75 [1.56-1.96],2.524238347695952e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF9,Protein turtle homolog A,19913,1888,1.72 [1.65-1.80],4.015480571368805e-122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10RB,Interleukin-10 receptor subunit beta,23025,2168,1.88 [1.69-2.09],2.646612900107833e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12A_IL12B,Interleukin-12,22833,2139,1.21 [1.15-1.27],7.157235145390456e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12B,Interleukin-12 subunit beta,23215,2189,1.31 [1.22-1.40],1.16467783019231e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12RB1,Interleukin-12 receptor subunit beta-1,22537,2110,1.61 [1.45-1.78],5.117356352278132e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,22655,2125,1.68 [1.43-1.97],2.508218876341963e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17RB,Interleukin-17 receptor B,22636,2144,0.73 [0.68-0.79],1.3568789193313293e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18,Interleukin-18,22828,2152,1.45 [1.34-1.57],3.225121206302803e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18BP,Interleukin-18-binding protein,23056,2165,1.75 [1.56-1.96],2.988556103473825e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18R1,Interleukin-18 receptor 1,23215,2189,3.35 [3.02-3.72],8.986594133164359e-114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R1,Interleukin-1 receptor type 1,22912,2163,2.82 [2.46-3.24],3.487564206375427e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R2,Interleukin-1 receptor type 2,22866,2154,3.45 [2.86-4.16],3.812916936949984e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL1,Interleukin-1 receptor-like 1,23154,2188,1.39 [1.28-1.51],9.978143346230267e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RN,Interleukin-1 receptor antagonist protein,22872,2154,1.59 [1.51-1.67],4.917940129941231e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6,Interleukin-6,22833,2139,1.26 [1.21-1.31],1.0198504037233075e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6ST,Interleukin-6 receptor subunit beta,22943,2160,2.65 [2.16-3.24],2.8320013649242745e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMMT,MICOS complex subunit MIC60,19841,1877,1.60 [1.49-1.73],2.597153270605508e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBC,Inhibin beta C chain,22954,2166,2.06 [1.85-2.29],1.4459606113153618e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL3,Insulin-like 3,19860,1881,0.84 [0.80-0.88],1.9609198892903093e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,22833,2139,1.24 [1.16-1.33],8.41857133245662e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA11,Integrin alpha-11,22920,2165,0.69 [0.62-0.77],5.815315235908274e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA5,Integrin alpha-5,22954,2166,2.98 [2.58-3.44],1.484533744207841e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAL,Integrin alpha-L,19320,1836,1.44 [1.30-1.60],2.059182602339666e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAM,Integrin alpha-M,22954,2166,1.65 [1.47-1.85],8.670600773822462e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB2,Integrin beta-2,22828,2164,2.13 [1.89-2.40],2.3802645336298608e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB6,Integrin beta-6,22537,2110,1.56 [1.37-1.77],6.042807915156029e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB7,Integrin beta-7,23146,2176,1.38 [1.28-1.49],4.441782336609991e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGBL1,Integrin beta-like protein 1,19921,1897,1.96 [1.79-2.14],1.726540341939141e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KCTD5,BTB/POZ domain-containing protein KCTD5,19476,1846,1.32 [1.21-1.44],4.1306744897051036e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KHK,Ketohexokinase,19360,1834,1.61 [1.50-1.73],1.505094565012285e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KITLG,Kit ligand,22943,2160,0.55 [0.50-0.61],5.838307400724052e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK4,Kallikrein-4,23146,2176,1.21 [1.14-1.28],2.629744448842904e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,23215,2189,1.83 [1.67-2.01],2.395924754333422e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT18,"Keratin, type I cytoskeletal 18",22833,2139,1.45 [1.40-1.50],2.381064768777477e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT19,"Keratin, type I cytoskeletal 19",22878,2161,1.32 [1.25-1.39],1.1965362905448863e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT8,"Keratin, type II cytoskeletal 8",19272,1835,1.30 [1.26-1.35],9.86576004146957e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KYNU,Kynureninase,23215,2189,1.60 [1.48-1.73],2.1684523323071124e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAG3,Lymphocyte activation gene 3 protein,22833,2139,1.39 [1.28-1.51],1.2724602336454488e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22907,2158,1.39 [1.28-1.50],9.676291739185487e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMB1,Laminin subunit beta-1,19360,1834,2.31 [2.00-2.68],6.144100048934958e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP1,Lysosome-associated membrane glycoprotein 1,19368,1850,1.43 [1.31-1.55],4.701918208537009e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP2,Lysosome-associated membrane glycoprotein 2,22244,2097,2.69 [2.23-3.25],8.335674665623596e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAYN,Layilin,22718,2148,1.47 [1.32-1.63],2.1720200874208091e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBP,Lipopolysaccharide-binding protein,23056,2165,1.28 [1.20-1.36],7.982396819956098e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBR,Delta(14)-sterol reductase LBR,23155,2176,1.18 [1.12-1.24],1.25157982576838e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLR,Low-density lipoprotein receptor,23008,2173,1.26 [1.18-1.36],2.520046459463795e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEP,Leptin,22943,2160,1.35 [1.27-1.43],1.0553457676942122e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LETM1,Mitochondrial proton/calcium exchanger protein,19874,1884,1.29 [1.20-1.39],2.0139816597692552e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3BP,Galectin-3-binding protein,19935,1892,2.01 [1.81-2.24],1.7592297281730818e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS4,Galectin-4,22907,2158,2.16 [2.04-2.29],2.473889975367121e-153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS9,Galectin-9,22913,2161,1.65 [1.47-1.85],3.527401900945158e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGMN,Legumain,23025,2168,1.49 [1.35-1.66],1.0462310096117527e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIFR,Leukemia inhibitory factor receptor,22920,2165,2.82 [2.46-3.23],5.305293423982616e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22913,2159,1.67 [1.49-1.87],2.388079228463288e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,23232,2193,1.88 [1.64-2.15],3.936505545595348e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,23120,2184,1.46 [1.31-1.63],3.6936994039591365e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPL,Lipoprotein lipase,22943,2160,0.56 [0.53-0.60],2.2209695874863606e-76
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPO,Lactoperoxidase,22139,2105,1.43 [1.35-1.52],1.4273325683380984e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19260,1830,1.61 [1.40-1.86],3.1799184832017277e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,22405,2098,1.29 [1.21-1.38],9.959566366662093e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY9,T-lymphocyte surface antigen Ly-9,22654,2130,1.57 [1.39-1.78],1.2572929320066324e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY96,Lymphocyte antigen 96,22750,2153,1.43 [1.29-1.57],6.359601097281522e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD3,Ly6/PLAUR domain-containing protein 3,22833,2147,1.60 [1.43-1.79],5.0922588378713653e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22680,2143,1.29 [1.22-1.37],8.211422882210713e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC4,Apical endosomal glycoprotein,19841,1877,1.42 [1.32-1.52],1.1535647424473404e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAN2B2,Epididymis-specific alpha-mannosidase,19913,1888,1.38 [1.28-1.48],5.78608676470929e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MASP1,Mannan-binding lectin serine protease 1,22718,2148,2.08 [1.77-2.45],1.1715439464203865e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN3,Matrilin-3,22707,2149,0.51 [0.45-0.57],8.404157452510515e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDK,Midkine,22929,2152,1.25 [1.17-1.34],1.4249399921783727e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MENT,Protein MENT,19456,1848,0.31 [0.26-0.37],2.488051464183614e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1A,Meprin A subunit alpha,19848,1888,1.30 [1.23-1.38],1.4665849619539601e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MET,Hepatocyte growth factor receptor,23006,2177,0.36 [0.29-0.43],1.9715159174815635e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP4,Microfibril-associated glycoprotein 4,19456,1848,1.84 [1.60-2.10],1.1643213688475222e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFGE8,Lactadherin,22954,2166,1.82 [1.69-1.97],7.239671285987035e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MILR1,Allergin-1,22537,2110,1.37 [1.28-1.48],4.3403158173325866e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MLN,Promotilin,22920,2165,1.14 [1.10-1.19],8.78319548246298e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MME,Neprilysin,22833,2139,1.40 [1.33-1.46],4.146129800746769e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP12,Macrophage metalloelastase,22978,2166,1.51 [1.41-1.61],8.824180516442024e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP7,Matrilysin,22499,2125,1.71 [1.57-1.85],1.6245113587398166e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP8,Neutrophil collagenase,23118,2173,1.23 [1.17-1.29],9.376399158951556e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP9,Matrix metalloproteinase-9,22919,2161,1.26 [1.18-1.34],1.9260838984746568e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRC1,Macrophage mannose receptor 1,19935,1893,2.15 [1.85-2.49],7.07442301621787e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSR1,Macrophage scavenger receptor types I and II,23155,2176,1.80 [1.67-1.94],1.3859788749873477e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTUS1,Microtubule-associated tumor suppressor 1,19560,1852,1.39 [1.30-1.49],1.5824418045844429e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC13,Mucin-13,22446,2110,2.04 [1.91-2.17],2.219556191181234e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MVK,Mevalonate kinase,22537,2110,1.44 [1.38-1.50],8.126358149596543e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MXRA8,Matrix remodeling-associated protein 8,19456,1848,0.31 [0.27-0.36],3.0565336696704478e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19456,1848,3.28 [2.69-3.99],2.355348519646211e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAN,Neurocan core protein,23155,2176,0.62 [0.56-0.68],2.4245886356232222e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN2,Nectin-2,22913,2159,1.87 [1.67-2.10],1.691876770390723e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEFL,Neurofilament light polypeptide,22380,2104,1.29 [1.21-1.38],9.503560755928826e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFASC,Neurofascin,23215,2189,5.59 [5.01-6.24],7.472128030428126e-206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22537,2110,1.34 [1.26-1.41],1.3890037489076502e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NHLRC3,NHL repeat-containing protein 3,18992,1799,2.90 [2.52-3.35],3.114160185249289e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NIT2,Omega-amidase NIT2,19833,1882,1.23 [1.15-1.30],4.1493018926985796e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOMO1,Nodal modulator 1,22954,2166,2.06 [1.77-2.41],4.489715571693375e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS3,"Nitric oxide synthase, endothelial",22446,2110,1.40 [1.32-1.48],4.915893473859193e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH1,Neurogenic locus notch homolog protein 1,23232,2193,2.19 [1.74-2.76],2.0191198839563765e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH3,Neurogenic locus notch homolog protein 3,23232,2193,0.65 [0.58-0.73],1.457954109537741e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPC2,NPC intracellular cholesterol transporter 2,19582,1865,1.81 [1.63-2.02],2.5269818257542088e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTX1,Neuronal pentraxin-1,22954,2166,1.37 [1.25-1.49],9.34363007966496e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPY,Pro-neuropeptide Y,23146,2176,1.49 [1.40-1.58],1.541124414799783e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRCAM,Neuronal cell adhesion molecule,22943,2160,2.86 [2.56-3.19],4.009419730438899e-80
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRP1,Neuropilin-1,23093,2169,2.04 [1.78-2.34],9.14740473212019e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,19860,1881,1.44 [1.29-1.60],1.1288133835045762e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5E,5'-nucleotidase,23005,2159,1.33 [1.24-1.42],1.1965983425130453e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK2,BDNF/NT-3 growth factors receptor,22943,2160,1.60 [1.38-1.86],3.377548895472389e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK3,NT-3 growth factor receptor,23155,2176,0.45 [0.38-0.54],1.4237191868822537e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OBP2B,Odorant-binding protein 2b,22669,2147,0.78 [0.74-0.84],6.275507165052305e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OCLN,Occludin,19874,1884,1.89 [1.74-2.06],1.5894468956612648e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLFM4,Olfactomedin-4,18731,1771,1.20 [1.15-1.24],4.037473216104562e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMD,Osteomodulin,23025,2168,0.58 [0.53-0.63],2.374148925680972e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSM,Oncostatin-M,22808,2155,1.28 [1.21-1.35],7.413593608436774e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSMR,Oncostatin-M-specific receptor subunit beta,23093,2169,2.20 [1.81-2.67],9.983124188105329e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OXT,Oxytocin-neurophysin 1,23155,2176,1.15 [1.12-1.18],6.265032450743553e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22530,2127,1.31 [1.23-1.39],8.66555424128815e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM2,Paralemmin-2,19860,1881,1.91 [1.74-2.10],4.888040147272785e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAMR1,Inactive serine protease PAMR1,22954,2166,2.26 [1.97-2.61],4.776778128047826e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBLD,Phenazine biosynthesis-like domain-containing protein,22446,2110,1.36 [1.28-1.46],7.699278837129513e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19417,1843,1.81 [1.68-1.95],3.9048443987476444e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH17,Protocadherin-17,22943,2160,1.86 [1.71-2.03],6.086145312302807e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH9,Protocadherin-9,19848,1888,1.59 [1.40-1.81],1.4164850949965205e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,23232,2193,1.66 [1.51-1.82],9.92977912728688e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1,Programmed cell death protein 1,23102,2173,1.34 [1.23-1.47],1.6008601819849503e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1LG2,Programmed cell death 1 ligand 2,22833,2139,1.55 [1.39-1.73],1.1057591006732035e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFRA,Platelet-derived growth factor receptor alpha,22943,2160,1.53 [1.34-1.74],3.8358738792370865e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19320,1836,1.84 [1.71-1.98],1.425525019010924e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGF,Placenta growth factor,23215,2189,1.90 [1.67-2.16],9.937010192216648e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIGR,Polymeric immunoglobulin receptor,22657,2133,2.50 [2.28-2.73],3.607083048490671e-88
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22954,2166,1.57 [1.39-1.78],3.179257456647669e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,22954,2166,1.59 [1.45-1.74],2.8574098310988304e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,22943,2160,1.38 [1.28-1.48],7.388434126941015e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD1,Polycystin-1,19913,1888,2.75 [2.33-3.24],2.368068070623088e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G15,Phospholipase A2 group XV,23005,2159,2.55 [2.25-2.90],4.625202523165922e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G1B,Phospholipase A2,23199,2191,0.71 [0.65-0.77],2.283215373960302e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G7,Platelet-activating factor acetylhydrolase,22954,2166,0.46 [0.41-0.51],7.774631579557518e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAT,Tissue-type plasminogen activator,23154,2188,1.36 [1.26-1.46],1.3983717901590426e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAUR,Urokinase plasminogen activator surface receptor,22755,2148,2.19 [1.93-2.48],5.710844668259439e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLTP,Phospholipid transfer protein,23166,2184,0.65 [0.59-0.71],4.0500359981768513e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXDC2,Plexin domain-containing protein 2,19860,1881,1.54 [1.36-1.75],2.1509445127215145e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNB2,Plexin-B2,23116,2185,5.76 [5.10-6.50],2.4943266893908626e-178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POF1B,Protein POF1B,19320,1836,1.34 [1.23-1.47],6.672424184024062e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON1,Serum paraoxonase/arylesterase 1,19935,1893,0.57 [0.50-0.66],1.6117657429579548e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON3,Serum paraoxonase/lactonase 3,23025,2168,0.59 [0.56-0.63],2.0591941523628128e-76
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRAP1,Proline-rich acidic protein 1,19921,1897,3.72 [3.28-4.22],1.0081265809429158e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRCP,Lysosomal Pro-X carboxypeptidase,23085,2181,3.24 [2.97-3.54],1.9073060283621336e-154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PREB,Prolactin regulatory element-binding protein,22537,2110,1.45 [1.30-1.62],8.206217928487715e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS8,Prostasin,22836,2149,2.35 [2.16-2.55],2.68228675088798e-89
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTG,Protogenin,23146,2176,1.60 [1.38-1.85],2.743245082409815e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAP,Prosaposin,19734,1880,1.63 [1.42-1.86],1.3796457619826004e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGR1,Prostaglandin reductase 1,19913,1888,1.40 [1.33-1.47],6.07588670639734e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTK7,Inactive tyrosine-protein kinase 7,22446,2110,1.41 [1.28-1.56],2.8694477414072478e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,19320,1836,1.34 [1.24-1.44],2.7521684467551155e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19913,1888,2.49 [2.16-2.87],5.568104577657986e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,19921,1897,1.95 [1.65-2.31],5.490803724600781e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,23232,2193,0.47 [0.42-0.54],1.8532732090163488e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,19848,1888,1.31 [1.20-1.43],9.826716544425896e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,22883,2160,1.84 [1.58-2.15],6.09815915552027e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,23232,2193,0.46 [0.40-0.53],2.6496257992427102e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,22333,2102,1.59 [1.51-1.69],8.035706641609959e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PVR,Poliovirus receptor,23155,2176,1.69 [1.54-1.84],2.807885892184177e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYY,Peptide YY,19234,1836,1.35 [1.30-1.41],2.122433044766769e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QDPR,Dihydropteridine reductase,22828,2150,1.32 [1.21-1.44],6.786492248735363e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QSOX1,Sulfhydryl oxidase 1,19535,1846,1.38 [1.28-1.49],1.1002663422204612e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB6A,Ras-related protein Rab-6A,22920,2165,0.74 [0.68-0.81],8.775080060932041e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES2,Retinoic acid receptor responder protein 2,23093,2169,1.37 [1.28-1.47],6.082855392923588e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBFOX3,RNA binding protein fox-1 homolog 3,19874,1884,1.56 [1.42-1.70],9.809262659640833e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP2,Retinol-binding protein 2,22833,2139,1.20 [1.15-1.26],1.4025434465277104e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP5,Retinol-binding protein 5,22833,2139,1.70 [1.60-1.81],2.47493336801735e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP7,Retinoid-binding protein 7,19848,1888,1.24 [1.17-1.32],6.582724514578968e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1A,Lithostathine-1-alpha,22827,2144,1.41 [1.32-1.51],1.8781354164478853e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1B,Lithostathine-1-beta,23232,2193,1.26 [1.19-1.34],7.912950364361228e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG4,Regenerating islet-derived protein 4,22943,2163,1.76 [1.64-1.89],5.895042556168354e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REN,Renin,22943,2160,1.49 [1.43-1.54],6.268307455240081e-90
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22833,2139,2.16 [1.95-2.39],3.799013925480698e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19456,1848,1.61 [1.49-1.74],7.930043196620665e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE1,Ribonuclease pancreatic,19935,1893,1.67 [1.42-1.95],2.2271438092381758e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE4,Ribonuclease 4,19286,1819,1.88 [1.64-2.16],2.1998523032960942e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE6,Ribonuclease K6,19801,1875,1.56 [1.41-1.72],8.179264091302423e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASET2,Ribonuclease T2,23122,2186,2.09 [1.84-2.38],4.1215842547890697e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF149,E3 ubiquitin-protein ligase RNF149,19360,1834,1.65 [1.44-1.89],6.247074243823573e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO1,Roundabout homolog 1,22943,2163,2.39 [2.08-2.76],4.175802625795697e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO2,Roundabout homolog 2,23155,2176,1.78 [1.51-2.08],1.6877220688880353e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,22405,2098,1.25 [1.17-1.34],1.3068378676584195e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4R,Reticulon-4 receptor,23146,2176,2.62 [2.41-2.85],3.4658181738862096e-114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100P,Protein S100-P,22530,2127,1.23 [1.15-1.30],3.107307566108818e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SAT2,Thialysine N-epsilon-acetyltransferase,19560,1852,1.23 [1.16-1.30],4.551080843495277e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARA5,Scavenger receptor class A member 5,23155,2176,2.04 [1.80-2.30],5.883541511160984e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARB2,Lysosome membrane protein 2,22301,2117,1.58 [1.42-1.76],5.644960593208925e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF2,Scavenger receptor class F member 2,23155,2176,1.57 [1.38-1.80],3.1929479458759114e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG2,Secretogranin-2,23051,2170,1.73 [1.55-1.94],7.56921306818461e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGN,Secretagogin,22537,2110,1.35 [1.24-1.47],2.0448634226030287e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCLY,Selenocysteine lyase,23084,2173,1.65 [1.53-1.77],2.858053274356505e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,19295,1829,1.39 [1.28-1.51],1.3413992360203904e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC1,Syndecan-1,22943,2160,1.49 [1.36-1.63],3.1009760940742214e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELE,E-selectin,23232,2193,1.89 [1.75-2.03],4.56463492581099e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELPLG,P-selectin glycoprotein ligand 1,22920,2165,2.13 [1.87-2.43],1.661524845866246e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA7A,Semaphorin-7A,23154,2188,2.07 [1.89-2.28],1.537275569962243e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA12,Serpin A12,22287,2107,1.12 [1.09-1.15],1.3361586736322097e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA4,Kallistatin,19576,1847,1.89 [1.57-2.29],4.218825745964726e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA9,Serpin A9,22736,2131,1.25 [1.19-1.32],5.117610580444176e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPIND1,Heparin cofactor 2,19902,1887,2.22 [1.91-2.59],6.028290521083009e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF1,Pigment epithelium-derived factor,19628,1863,2.66 [2.29-3.09],6.652794465522721e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP4,Secreted frizzled-related protein 4,19456,1848,1.43 [1.28-1.60],2.600742037646436e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SGSH,N-sulphoglucosamine sulphohydrolase,19590,1858,1.34 [1.25-1.45],7.928294423238441e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHBG,Sex hormone-binding globulin,19935,1893,0.58 [0.53-0.63],3.176617368698078e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHISA5,Protein shisa-5,19921,1897,1.73 [1.50-2.00],5.62800461165028e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",22989,2166,1.15 [1.10-1.21],5.711137475329742e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIAE,Sialate O-acetylesterase,22964,2156,1.34 [1.24-1.45],3.9890927447186613e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC1,Sialoadhesin,23025,2168,1.65 [1.51-1.80],6.967091897209433e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22920,2165,1.73 [1.58-1.90],8.224448853094058e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,23146,2176,1.92 [1.73-2.14],4.175648193905259e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,22943,2160,2.80 [2.47-3.17],9.00107418106848e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19360,1834,1.56 [1.42-1.72],1.584189691333643e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,23111,2175,1.53 [1.36-1.73],3.8646866820433786e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPB1,Signal-regulatory protein beta-1,22863,2153,1.32 [1.22-1.43],5.11502999287036e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,22537,2110,1.56 [1.46-1.67],8.639163111555362e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKAP1,Src kinase-associated phosphoprotein 1,22718,2148,1.19 [1.13-1.25],2.1299218358956275e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF1,Signaling lymphocytic activation molecule,22537,2110,1.36 [1.28-1.46],3.296602620388513e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF7,SLAM family member 7,22920,2165,1.23 [1.16-1.31],5.3047292829452426e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF8,SLAM family member 8,22405,2098,1.45 [1.35-1.57],1.1038809974079188e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19848,1888,1.25 [1.16-1.34],9.310484750312523e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLIT2,Slit homolog 2 protein,22446,2110,1.25 [1.17-1.33],1.2717392729964811e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK2,SLIT and NTRK-like protein 2,23146,2176,1.47 [1.34-1.61],2.8886182876059873e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC1,SPARC-related modular calcium-binding protein 1,23146,2176,1.70 [1.53-1.88],3.5611470259949266e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD1,Sphingomyelin phosphodiesterase,23040,2167,1.31 [1.22-1.41],1.1181951056590321e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORD,Sorbitol dehydrogenase,23046,2168,1.37 [1.29-1.45],3.255877551737543e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORT1,Sortilin,22913,2159,1.39 [1.26-1.53],3.132795585477554e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK1,Serine protease inhibitor Kazal-type 1,22954,2166,1.77 [1.63-1.92],1.166891325349611e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK4,Serine protease inhibitor Kazal-type 4,22920,2165,1.43 [1.36-1.51],1.3849107650884223e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT1,Kunitz-type protease inhibitor 1,22866,2156,1.93 [1.71-2.19],2.7325344964608202e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT2,Kunitz-type protease inhibitor 2,23025,2168,1.37 [1.25-1.51],6.059425142728211e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON1,Spondin-1,22943,2163,1.69 [1.53-1.86],5.532430111859043e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON2,Spondin-2,22832,2150,2.02 [1.82-2.25],9.3088909428269e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22913,2159,1.13 [1.10-1.17],2.656928844583676e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,23056,2165,1.74 [1.60-1.90],9.048381003399636e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23232,2193,1.57 [1.41-1.75],8.60713393331874e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAB2,Stabilin-2,19921,1897,2.09 [1.79-2.45],7.043512478598948e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC1,Stanniocalcin-1,23155,2176,1.45 [1.35-1.57],2.588920525673991e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SULT2A1,Bile salt sulfotransferase,22920,2165,1.45 [1.38-1.52],2.0342104504236736e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUOX,"Sulfite oxidase, mitochondrial",19874,1884,1.42 [1.34-1.51],1.4349292338533353e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD5,Sushi domain-containing protein 5,19358,1839,0.61 [0.54-0.70],2.781868715826148e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN2,Transcobalamin-2,23198,2189,1.79 [1.60-2.00],4.8004969337025864e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCOF1,Treacle protein,19913,1888,1.62 [1.46-1.79],1.4937641700132008e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCTN3,Tectonic-3,19913,1888,1.65 [1.43-1.90],6.401472580686513e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEK,Angiopoietin-1 receptor,23005,2159,2.47 [2.09-2.92],1.6770459803744268e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF1,Trefoil factor 1,22846,2156,1.25 [1.20-1.31],6.834936723954209e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF2,Trefoil factor 2,22989,2166,1.52 [1.43-1.61],5.748224162777103e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF3,Trefoil factor 3,22945,2152,1.52 [1.41-1.65],5.5242212228579975e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI2,Tissue factor pathway inhibitor 2,22941,2156,1.31 [1.22-1.40],1.465189327330656e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFA,Protransforming growth factor alpha,22920,2165,1.55 [1.44-1.67],8.546475045928672e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFB1,Transforming growth factor beta-1 proprotein,23178,2185,1.52 [1.39-1.65],7.526183522510817e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR2,TGF-beta receptor type-2,23005,2159,1.39 [1.25-1.54],3.712397494682522e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS2,Thrombospondin-2,22954,2166,2.07 [1.92-2.24],1.3085658330995878e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS4,Thrombospondin-4,22986,2161,1.35 [1.25-1.47],3.387945916867281e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THOP1,Thimet oligopeptidase,22835,2153,1.54 [1.38-1.72],5.746124463870856e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP1,Metalloproteinase inhibitor 1,22725,2130,1.94 [1.72-2.18],1.0000626562395614e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP4,Metalloproteinase inhibitor 4,22954,2166,0.70 [0.64-0.78],5.5964820400711956e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR3,Toll-like receptor 3,23215,2189,1.28 [1.20-1.37],5.874153253618463e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS15,Enteropeptidase,22833,2139,1.28 [1.23-1.34],8.117440260714395e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNF,Tumor necrosis factor,22499,2125,1.37 [1.26-1.49],2.729855412192539e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22750,2153,1.95 [1.81-2.11],5.184257138438016e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22750,2153,1.32 [1.26-1.38],5.045877066474496e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23215,2189,1.94 [1.78-2.12],3.337231278523928e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22907,2158,2.30 [2.06-2.57],9.296395037457855e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,23005,2159,1.75 [1.59-1.93],4.823082841395519e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22943,2163,1.61 [1.44-1.81],3.2230550025937453e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22954,2166,1.99 [1.79-2.22],2.410308988966394e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22954,2166,1.53 [1.42-1.64],3.7825181852373456e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23178,2185,1.56 [1.42-1.71],8.276322047641628e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22750,2153,1.24 [1.17-1.32],3.17522543266636e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22750,2153,1.39 [1.28-1.50],3.1071437497790107e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,23215,2189,0.51 [0.44-0.59],5.617467041891159e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,22920,2165,0.77 [0.72-0.82],4.317490736960566e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,23215,2189,0.51 [0.44-0.58],2.6798292420528144e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,23025,2168,1.61 [1.41-1.84],1.894049404795281e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23195,2192,1.54 [1.36-1.75],2.5549959358449475e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,19921,1897,1.57 [1.40-1.76],4.5446793371596216e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNN,Tenascin-N,19921,1897,1.45 [1.32-1.61],3.53216947292082e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TP53I3,Quinone oxidoreductase PIG3,19031,1798,1.30 [1.20-1.41],1.3669502220856934e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPK1,Thiamin pyrophosphokinase 1,19913,1888,0.53 [0.45-0.62],8.144073250389168e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPP1,Tripeptidyl-peptidase 1,22755,2142,1.45 [1.36-1.56],1.638466085259188e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREH,Trehalase,19921,1897,1.54 [1.45-1.64],1.8323588846292226e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREM2,Triggering receptor expressed on myeloid cells 2,22907,2158,1.36 [1.28-1.46],1.7972116529379934e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22954,2166,1.30 [1.21-1.41],3.149923769139758e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ULBP2,UL16-binding protein 2,22750,2153,1.58 [1.44-1.72],1.409319400374652e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UMOD,Uromodulin,23153,2186,0.75 [0.70-0.80],1.7835305208094422e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPB1,Beta-ureidopropionase,19913,1888,1.45 [1.39-1.51],2.750807263243523e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22833,2139,0.40 [0.32-0.48],1.3973621134868452e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAM1,Vascular cell adhesion protein 1,23022,2164,1.75 [1.54-2.00],7.490725828058385e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VMO1,Vitelline membrane outer layer protein 1 homolog,22833,2139,1.30 [1.23-1.39],2.782646291679027e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN1,Pantetheinase,19935,1893,1.38 [1.30-1.48],2.1754608280517826e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN2,Vascular non-inflammatory molecule 2,22833,2139,1.36 [1.25-1.48],1.9504256618619216e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,19841,1877,1.47 [1.39-1.56],1.3647983316798865e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,22926,2164,1.58 [1.45-1.73],2.4120214402321984e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22530,2127,1.21 [1.15-1.29],2.1155873731501284e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC2,WAP four-disulfide core domain protein 2,21796,2050,1.47 [1.35-1.60],4.103377021957177e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22943,2163,0.70 [0.63-0.78],6.636560094663445e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WIF1,Wnt inhibitory factor 1,23146,2176,0.61 [0.55-0.69],1.7383655870630057e-17
